chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an 18 year old female who on 22-JUN-2007 was vaccinated with a first dose of Gardasil. Immediately following the vaccine, the patient fainted. The patient was laid down and watched for ten to fifteen minutes. After that time, the patient was fine and had recovered from fainting. Additional information has been requested.
Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Headaches, pain in the head and neck, joint pain, muscle ache, lethargic. Diarrhea, nauseous, vomiting, dehydration. I went to the urgent care locally. I was given medication.
Fever, chills, headache, fatigue lasting approximately 36 hours. Missed work 1/27 and 1/28/21
Woke up in the middle of the night sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Woke up in the middle of the night sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Woke up in the middle of the night sick). At the time of the report, ILLNESS (Woke up in the middle of the night sick) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant use were reported. No Treatment were reported.   This case was linked to MOD-2022-449904, MOD-2022-449915 (Patient Link).
one hour post vaccination, patient had tingling on left face. Near ear to jaw line radiating to neck. Lasted one hour then resolved.
Bullos lesions forearms  & legs Ongoing problem Complicated by Erysipelas. Test compatible with Bulluos Pemphigoid
herpes zoster; Information has been received from a lawyer and a female patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a physician at physician office for herpes zoster. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Narrative:  patient did not experience adverse event- reporting is of inconsistent vaccination schedule due to lack of information. Provider was inclined to believe patient was in need of COVID vaccination and received his "first" Pfizer vaccination 5/15/2021 which later turned out to be his third- he was previously vaccinated with Moderna on 2/18/21 and 3/18/21 from a non-Facility source which was not documented in his chart.
At time of injection for tdap vaccine, pain radiated down the front of my arm into my elbow as the injection was occurring. Afterward, right arm was sore but assumed it was normal discomfort from shot. That evening my right arm and shoulder were very sore. The following day I had decreased ROM and my arm and shoulder were increasingly sore. I slowly lost my ability to move my arm without pain over the course of the day and had severe loss of ROM. By the second day after the shot, I couldn't move my right arm without severe pain, had sleep interruptions from the pain, and had pain and discomfort while just sitting still. Over the course of several days, the pain got worse. 10 days after the shot, my pain began to decrease and I've been able to move my arm more, but I still don't have full ROM and I am not pain free.
This spontaneous report was received from a registered pharmacist refers to patient of unknown age (gender unspecified). On 29-NOV-2012, the patient was vaccinated with 0.65 ml ZOSTAVAX, (lot number reported as 1269AA, expiration date 05-NOV-2012), subcutaneously which had expired on 05-NOV-2012. No concomitant medications were reported and no adverse effects reported. Additional information has been requested.
Chest pain, cough, head congestion, runny nose, sore throat, headache, fatigue, aches
PT STATED THE RASH APPEARED ABOUT 5 TO 6 DAYS AGO FROM (TODAY'S DATE: 12/11/17@ 4:46PM). PT'S ARMS DEVELOPED RASH & ARE VERY RED & EXTREMELY "ITCHY". BUT ITCHINESS IS STARTING TO SUBSIDE A BIT. PT ALSO DEVELOPED RASH & TINY BUMPS ON THE FOLLOWING AREA(S): BREAST (AROUND THE NIPPLES), ANKLES UP TO KNEES BUT NOT ITCHING.
On Sunday evening I was feeling off and down (like depressed), like I had no desire to live. I finally went to sleep and woke up and tried to work. I couldn't focus and was overwhelmed with sadness. I felt like I could just drive my car off a cliff. I have never felt like THIS before. I called my work crisis line and they didn't answer. I drove to the crisis center, but then our work's crisis line called me back and she was such a peach, seriously a gem, she perfectly described how I was feeling in her own words. She calmed me down a bit and I called the doctor's office. I got an appointment that day and he told me to take a lorazepam (I have them for panic attacks with anxiety), but I thought lorazepam makes you feel down (because I take it when I'm "up" or panicking). I took 1/2mg and was feeling so much better. I then saw my therapist on Tuesday evening and we talked through the concerns. While I have anxiety/panic disorder, I have never felt so LOW.  Thanks for listening!
Rash lasted for 4-5 weeks and was in face, arms, legs and head also itchy treated with topical steroid.
Information was received from a pharmacist concerning a male patient (age not specified). The pharmacist reported that on an unspecified date the patient received a second dose of PNEUMOVAX 23, .5 ml, intramuscular. The patient had received the first dose of PNEUMOVAX 23 approximately two years prior. The patient was supposed to have been vaccinated with PREVNAR 13 instead of the PNEUMOVAX 23. No adverse effects were reported. No further information was provided. Additional information is expected.
outer left corner of her eye had been painful to the touch and the pain radiates inside of her head; headache/internal inflammation; fever; visual changes, objects appearing smaller; This is a spontaneous report from a contactable consumer(patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported ), via an unspecified route of administration, administered in left arm on 10Apr2021 as SINGLE DOSE for covid-19 immunization. Patient medical history and concomitant medications were not reported. The patient had her first dose of Bnt162b2 on an unspecified date. On 11Apr2021, sunday patient had "normal side effects" including fever. On Wednesday, 14Apr2021, she reports that the outer left corner of her eye had been painful to the touch, and the pain radiates inside of her head, and that her eye is not visibly swollen. The headache/internal inflammation has resulted in visual changes, specifically objects appearing smaller than previously. She states that the visual changes are present even if she closes her left eye, and just looks out of her right. She also stated that she closes her left eye the vision changes remain. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Symptom onset was on 1/30. I had headache, fatigue, large amount of sinus drainage and a sore throat. My usual treatment would be TYLENOL sinus and CHLOR TRIMETON. On 2/1 I did a home COVID-19 test and it was positive. I contacted my doctor through the online portal and she left the decision to me if I wanted to do PAXLOVID. I did want to take it, she prescribed it online. I started it on 2/2/2023. I finished it on 2/7/2023. On the 12th I tested negative using a home COVID-19 test. On the 17th my symptoms began to reoccur, same symptoms. The fatigue was the worst of it. I did have a little bit of an upper respiratory cough. I also tested positive again and I stayed positive and symptomatic through the 27th. I did not contact my doctor again I did home care. The PAXLOVID was helpful and did help to decrease my symptoms.
12yo child complained of very itchy arm and redness after second dose of pfizer covid 19 vaccine. Offered dose of childrens benadryl 10ml to grandmother whom gave permission to administer. Grandmother  stated child was 105/110 pounds. Family and patient left 15 min later with no further complaints
Patient received an expired vaccine. Vaccine expired on 4/27/2023 and was given on 5/5/2023. Patient has been notified and will repeat vaccine.
Injection Site got red, hot and is swollen. The area has grown in 2 days.
Chest and back pain, legs weak since COVID shot 10 days prior; Feet feel like "pins and needles". Lower extremity weakness and paresthesia's and low back pain which now extend to her hands. Unsteady gait.  No urinary or vowel incontinence. No similar reports from other vaccinations
administered an expired Dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA392A, expiry date 31st October 2021) for prophylaxis.   On 5th November 2021, the patient received Menveo. On 5th November 2021, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. A pharmacist reported that, the patient was administered with an expired Menveo, which led to expired vaccine used.
Muscle spasms in left arm, forearm.  Muscle aches in left fingers and left leg, at 3:00 am 4/10/2021.  Left wrist pain at 7:00am 4/10/2021?
Pt contacted me to report: fever (100.5), chills, nausea and body aches; injection site redness and firm swelling "about the size of a baseball" Pt advised to use warm soaks, topical hydrocortisone cream, Tylenol &/or Ibuprofen for symptom relief. Symptoms resolved by 4/26/10
Patient said heart rate was elevated for 48 hours after vaccine and also had "heart fluctuations."  Patient did not seek medical care
Menactra was administered after expiration with no reported adverse event; Initial information received on 02-Aug-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 18 years old male patient to whom MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] was administered after expiration with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 02-Aug-2022, the patient received as indicated dose 2 (booster)  of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE, (frequency: once) ( lot: U6951AA ; expiry date: 06-Jun-2022) via intramuscular route in the deltoid nos for immunization.  It was reported that Menactra was administered after expiration with no reported adverse event (expired product administered) (latency: same day)    Action taken : Not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
got the shot. Then got shingles/Suspected Vaccination failure; got the shot. Then got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's spouse. The age at vaccination was not reported. The patient got the Shingle shot and then got shingles, still had a patch on forehead, a patch on boob and the patch on waist for three years. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
WHILE INJECTING WITH AN EASY POINT NEEDLE 25G 5/8IN SAFETY SYRINGE ON A LUER-SLIP MONOJECT 1CC SYRINGE, THE SYRINGE WAS FORCED OUT OF THE NEEDLY WHILE PRESSING PLUNGER AND VACCINE  SPRAYED OUT ALL OVER THE PATIENT AND MYSELF.  REVACCINATED WITH ANOTHER PREFILLED SYRINGE USING VANISHPOINT
This spontaneous report as received from a other health professional refers to unspecified number of patients of unknown age. It was reported that the PEDVAXHIB of unknown dose, have undergone a second temperature excursion dated 2-JUL-2014 and have been administered post initial excursion reported as 16-JAN-2014. Excursion supported. It was reported that no adverse events and no concerns are reported by any patients. PEDVAXHIB have been administered since date of last excursion of 27-JAN-2014 is with Lot number J010385 and expiry date 28-MAY-2016. This is one of the several reports from the same source: different patients same reporter. Additional information has been requested.
Red, hot, swollen spot for over a week  Kenalog ointment applied locally
Diffuse body aches starting 02/02/21 daily and still present on 02/07/21. No fever or other symptoms. Covid 19 test negative on 02/06/21.l
15 minutes after patient received injection she stated that the area where she was injected itched a little bit.  We had her wait another 5 minutes or so and only the area at the injection site itched still.  I recommended some ice and ZYRTEC and a phone call to her Dr if no improvement.
Starting the morning after the Vacinne I felt woozy, tired  and had mild headache.   I was not safe to drive that day and today.   Head still feels achey and I am still tired and spacey feeling.    Patients should be cautioned to have no activities for several days after both doses.
administered only the ASO1B adjuvant component of the vaccine; administered only the ASO1B adjuvant component of the vaccine; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number 75P#7, expiry date 3rd June 2023) for prophylaxis.   On 1st April 2022, the patient received the 1st dose of Shingrix. On 1st April 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 01-APR-2022 Reporter's Comments:  The reporter administered only the ASO1B adjuvant component of the Shingrix vaccine to a husband and wife. The reporter was not sure which of them received only the diluent or the full vaccination. The reporter consented to follow up. Additional Supportive Information: The reporter administered only the ASO1B adjuvant component of the Shingrix vaccine to a patient in left arm, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered This case is linked with case US2022058812 reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022058812:same reporter
Received MMR and Hepatitis B vaccines on 7/29/20 - called 7/31/20 that her arm had red swollen area from MMR vaccine - . No further increase in swelling - some pain localized reaction per description advised Tylenol, cool/ice, allergy med orally.
Mom reports child exposed to her father with shingles 10/26/04. Child developed blistered rash 11/05/04 with 15 lesions, with itching, T96.8 x24 hrs after breaking out.
pt recv vax; reported to have had "shrill" cry intermittent,lasting approx 4 hr;mom did not rpt hx prior to pt's vax; fever 101-102 ;
patient was given 2nd dose of the vaccine 14 days after the 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient was given 2nd dose of the vaccine 14 days after the 1st dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Screaming for 24 hours, stiffness, extremely high fever, no eye contact, refusal to be held or comforted, refusal to eat, inconsistent responses to external stimuli. Treated with Tylenol but child never the same. From that point child had sensory issues and extreme levels of anxiety. Child diagnosed with autism at 2 years of age. Currently being treated with 20 hours of therapy a week, special diets, and medication. 2/12/08-records received-C/O speech delay, regressed in speech at age 1 year. Self stimulating behavior, spins in circles and flaps his hands. Does not socially interact. DX: Speech delay. Pervasive developmental disorcer.  1/20/2010 Anxiety, sensory issues, toxic levels of metals in system, infections, G!  problems, lack of social ability.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 17-JAN-2017 at 08:46, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
pt recvd vax & became ill after vax; pt had high fever, hallucinations
As patient was walking out of building, approximately 15 minutes following vaccination, had sudden onset of ringing of ears, headache and lightheadedness.  Did not report this to facility. Headache persisted for 24 hours. On 1/30/10, while kneeling at church, fainted.  Mother raised her legs and child recovered quickly.  Did not seek medical care.
Pt complained of pain in left arm.. He stated his arm felt numb. I asked pt to stay in clinic for a few more minutes to assess his status while charting. Patients head lowered and he became stiff and leaned to the left on the desk.. clinched fists and tremors. With help from his mother, he was lowered to the floor on his knees. Code Blue called. Moved all furiture away from pt to prevent injury. Pt only able to mumble and was incoherent when asked questions. Ambulance arrived. Pt moved up to a chair and transferred to gurney. Pt stated he could not see.
The child's father reported a fine rash and white spots on his tongue and itching of skin rash.
States she experienced dizziness, ringing in ears, headache, neck pain  - resolved by 10/22/23. Hit her head on 10/23/23 and she experienced the same symptoms.